| Market revenue in 2024 | USD 2.2 million |
| Market revenue in 2030 | USD 3.5 million |
| Growth rate | 7.8% (CAGR from 2025 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Preclinical |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Preclinical |
| Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
Publish Date: Jul 15, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Icon PLC | View profile | 41,150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | www.iconplc.com |
| IQVIA Holdings Inc | View profile | 87,000 | 2400 Ellis Road, Durham, NC, United States, 27703 | www.iqvia.com |
| SGS AG | View profile | 103,193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | www.sgs.com |
| Intertek Group PLC | View profile | 44,000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | www.intertek.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | www.syneoshealth.com/ |
| Pace Analytical Services | View profile | 11-50 | Woburn, Massachusetts, United States, North America | www.pacelifesciences.com |
| Toxikon | View profile | 101-250 | Bedford, Massachusetts, United States, North America | www.toxikon.com/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Large Molecule Bioanalytical Testing Services Market Outlook will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 72.73% in 2024.
Horizon Databook has segmented the Kuwait large molecule bioanalytical testing services market based on clinical, preclinical covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait Large Molecule Bioanalytical Testing Services Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Kuwait Large Molecule Bioanalytical Testing Services Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.